Latest News
-
1:10 Split, Rs 299/Sh Dividend: Tata's Steel Stock Up 11% In 30-Days, Better Than Nifty; PL Says Accumulate -
625% Dividend, 1:10 Split, 3 Bonus; FMCG ITC Makes Big Acquisition Announcement; Stock Target Prices In April -
2:1 Bonus Issue: IT Penny Stock Turned; 1,600 Shares Market Lot Size Revised To 4,800 Shares -
FREE, FREE, FREE! 3:1 Bonus: Pharma Stock Hits Back-To-Back Upper Circuits; 500 Shares To Earn Rs 1,69,500 -
1:10 Stock Split: Below Rs 10, Fertilizer Sector Turned Ex-Split; 8,282% Returns In 5 Years -
Rs 17/Share Dividend: Record Date On April 26; Buy The ICICI Group Stock To Be Eligible? -
Honasa Consumer to Strengthen Operations by Merging Fusion Cosmeceutics and Just4Kids -
Wipro Reports 7.8% Decline in Q4 Net Profit; CEO Highlights Economic Challenges -
IREDA Hits Record Annual PAT of Rs 1,252 Cr in FY24; Q4 Profits Up by 33% -
Massive Employee Exodus Hits India's Top IT Companies in FY23-24
3 Pharma & Diagnostics Stocks, 2 Of Them Trading Near 52-Week Low, Get Buy Call: BNP Paribas
BNP Parisbas Securities has recommended investors to buy three pharmaceuticals stocks showing rising trend. These stocks are JB Chemicals & Pharmaceuticals Ltd, Dr. Lal Pathlabs Ltd, and Aurobindo Pharma Ltd. 2 of these pharma stocks are currently trading near their 52-week low price. If investors buy these stocks now, they will get maximum return 31% return. Check details below:
1. Buy JB Chemicals & Pharmaceuticals Ltd
BNP Paribas Ltd has assigned buy call to JB Chemicals & Pharmaceuticals with a target price of Rs 2342 apiece. The current market price of the stock is Rs 1952 apiece with intraday surge of 0.32%.
If you buy JB Chemicals & Pharmaceuticals Ltd, you will get 20% return. The stock's 52-week high is Rs 2149 apiece and 52-week low is Rs 1339 apiece, respectively. It has a market capitalisation of Rs 15,100 crore.
The mid cap stock came into existence in 1976 and has given return of 13% in last 1-year, 324% in last 3-years, and 480% in last 5-years.
2. Buy Dr. Lal Pathlabs Ltd
The analyst has recommended investors to buy Dr. Lal Pathlabs Ltd with a target price of Rs 2820 apiece. If you buy Dr. Lal Pathlabs Ltd now, you will get 31% likely return soon.
The mid cap stock operating Diagnostics industry has a market capitalisation of Rs 18038 crore. The current market price of the stock is Rs 2164 apiece with 52-week high quoted at Rs 3768 apiece and 52-week low at Rs 1805 apiece, respectively.
The stock is also trading near its 52-week low price and currently just 16% away from 52-week low price.
The shares of Dr Lal Pathlabs have rallied 33% in last 3-years and 135% in last 5-years. It has declined 41% in last 1-year.
3. Buy Aurobindo Pharma Ltd
The brokerage firm has given buy call to Aurobindo Pharma Ltd with a target price of Rs 564 apiece. The current market price of the stock is Rs 431 apiece with an intraday fall 3.33%. If you buy Aurobindo Pharma Ltd now, you will get potential 31% return.
The stock's 52-week high is Rs 730 apiece and 52-week low is Rs 429 apiece. The current stock price is now just 0.46% away from 52-week low price. The stock has declined 39% in last 1-year and 16% in last 3-months.
The large cap pharmaceuticals company was incorporated in 1986. The company has a market capitalisation of Rs 25,274 crore.
Disclaimer
The stocks have been picked from the brokerage report of BNP Parisbas Securities. Greynium Information Technologies, the Author, and the respective Brokerage House are not liable for any losses caused as a result of decisions based on the article. Goodreturns.in advises users to check with certified experts before taking any investment decision.
